Drug Topics
JULY 22, 2024
Researchers aimed to determine the risks and benefits of prescription drug advertising released in tandem with disease awareness programming.
STAT
JULY 22, 2024
Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to a federal audit. The findings are likely to intensify scrutiny of the controversial role played by PBMs in the opaque pharmaceutical pricing system.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 22, 2024
Study investigators surveyed nearly 200 women on their concern around period-tracking apps’ data practices, as well as whether Roe v Wade being overturned influenced their concerns.
STAT
JULY 22, 2024
Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. Public health experts who’ve been following the surprising spillover of H5N1 bird flu into America’s dairy cattle herds now have all eyes on Colorado, waiting to see if a cluster of human cases there might balloon into something bigger.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JULY 22, 2024
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss Pharmacy Benefit Managers.
STAT
JULY 22, 2024
People under 45 have been driving an increase in liver-related deaths, especially those caused by alcohol. But a sliver of that young adult population is being hit disproportionately hard by alcohol-associated liver disease: transgender people. Although trans adults make up less than 1% of the United States population, a study published in The American Journal of Gastroenterology last month shows they face double the risk of severe liver disease, and a higher share of cirrhosis from heavy drinki
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 22, 2024
It seems like organized chaos. Five lab members move around a room the size of a galley kitchen. On this day, three high school students also squeeze into the medical lab, closely peering at a pig heart barely beating in a box. Tubes connected to the heart from a rhythmic, speaker-like pump push warm red blood cells through its chambers. It looks like a scene out of Frankenstein.
Fierce Healthcare
JULY 22, 2024
Abridge has spent the last six years building generative AI tools to help doctors with medical documentation and is now putting that technology in the hands of hospital nurses. | Abridge has spent the last six years building generative AI tools to help doctors with medical documentation and is now putting that technology in the hands of hospital nurses.
STAT
JULY 22, 2024
In a ground-breaking settlement with the Federal Trade Commission, two online addiction and mental health treatment companies, Monument and Cerebral , admitted to deceptively and widely sharing sensitive personal and health information with third-party advertising platforms including Meta (Facebook) and Google. They aren’t alone. Our research at the Opioid Policy Institute has found more than a dozen other online addiction treatment companies engaging in similar deceptive behavior that co
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 22, 2024
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Express Scripts overcharged your mail carrier Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to an under-the-radar federal audit that my colleague Ed
Pharmacy Times
JULY 22, 2024
Eculizumab-aagh does not have an interchangeable designation, though that could be updated in the future.
STAT
JULY 22, 2024
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or two of stimulation.
pharmaphorum
JULY 22, 2024
Learn how applying intercultural intelligence can promote growth and success in the dynamic and diverse business environment of the Middle East. Gain insights and strategies for effective cross-cultural communication and collaboration.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
JULY 22, 2024
As lawmakers and industry groups seek to get a handle on U.S. | As lawmakers and industry groups seek to get a handle on U.S. drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat.
The Checkup by Singlecare
JULY 22, 2024
Metronidazole (brand name Flagyl) is a nitroimidazole antibiotic that is most commonly used to treat vaginal infections, certain sexually transmitted diseases (STDs), and gastrointestinal infections such as H. pylori. It can also treat parasitic infections, like giardia, and is frequently used off-label (for a non-FDA-approved use) to help treat Crohn’s disease, bite wounds, and oral infections.
Drug Topics
JULY 22, 2024
The approval of eculizumab-aagh offers more treatment options for patients with rare diseases PNH and aHUS.
Pharmacy Times
JULY 22, 2024
In the session at the 2024 American Association of Colleges of Pharmacy Annual Meeting, presenters highlighted the importance of fostering inclusion for LGBTQ students.
Fierce Healthcare
JULY 22, 2024
Advocates meet with White House to urge inclusion of Adderall, other stimulants in upcoming telehealth prescribing rule ebeavins Mon, 07/22/2024 - 14:43
Drug Topics
JULY 22, 2024
The most common adverse events in patients using oral corticosteroids for more than 90 days included fracture, hyperlipidemia, myocardial infarction, and avascular necrosis.
STAT
JULY 22, 2024
Following a two-year probe, the European Commission has formalized a proposal from Vifor Pharma to resolve allegations that the company spread misleading information about a rival treatment to its blockbuster drug for iron deficiency. The move came after a complaint that Vifor may have disparaged its “closest and, potentially, only” competitor to its Ferinject medicine in the European market.
Fierce Pharma
JULY 22, 2024
After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. | Agilent has revealed that it’s signed a definitive agreement to acquire Biovectra for $925 million through a mix of cash and debt financing. The deal is expected to close this year.
pharmaphorum
JULY 22, 2024
The recent action by the FDA mandates that trial sponsors must consider diversity in clinical trials. Learn more about the importance of diversity and inclusion in medical research.
Fierce Pharma
JULY 22, 2024
At his vacation home in Delaware, President Joe Biden made the striking announcement that he is dropping out of the 2024 | While President Joe Biden is officially out for the 2024 election, his term has certainly made a mark in the healthcare realm.
pharmaphorum
JULY 22, 2024
Consumer wearables have shown a benefit when used to monitor treatment responses in patients with atrial fibrillation and heart failure.
Pharmaceutical Technology
JULY 22, 2024
As VP Kamala Harris enters the presidential race, her strong stances for reproductive rights and drug access offer insights into future actions.
Pharmacy Times
JULY 22, 2024
Educators should prioritize integrating social determinants of health (SDOH) for the next generation of pharmacists.
pharmaphorum
JULY 22, 2024
Scientists at OHSU in the US have developed a universal form of influenza vaccine that they say could protect against all strains of the virus
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
Drug Topics
JULY 22, 2024
Check out important updates from the FDA from over the past week.
Fierce Healthcare
JULY 22, 2024
Several employees of the Department of Health and Human Services (HHS) posted on LinkedIn inviting industry professionals to apply for senior executive roles in the agency to lead initiatives on te | The Department of Health and Human Services will hire three new senior executives to oversee data, technology and artificial intelligence strategies within the Department, several HHS employees posted on LinkedIn over the weekend.
Fierce Pharma
JULY 22, 2024
Grünenthal has continued its expansion splurge, | Grünenthal has continued its expansion splurge, acquiring Valinor Pharma and its lone commercial product Movantik (naloxegol), a treatment for opioid-induced constipation (OIC), for $250 million.
pharmaphorum
JULY 22, 2024
Pain medicine specialist Grünenthal has agreed to buy Valinor Pharma for $250m, getting control of Movantik for opioid-induced constipation
OctariusRx
JULY 22, 2024
This week we are once again providing an update on the most recent drug shortages. Drug shortages currently remain at over 100 different medications, with the Food and Drug Administration (FDA) noting 109 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
Expert insights. Personalized for you.
187 
Let's personalize your content